ACCRUED EXPENSES |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Payables and Accruals [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ACCRUED EXPENSES | Note 8 ACCRUED EXPENSES
At March 31, 2026 and December 31, 2025, accrued expenses consisted of the following:
Included in the accrued payroll and related liabilities presented in the table above was approximately $7.3 million and $6.6 million at March 31, 2026 and December 31, 2025, respectively, for past due payroll taxes and associated penalties and interest.
In addition to the current portion of the Medicare cost report settlement payables of $710,120 and $690,474 presented in the table above at March 31, 2026 and December 31, 2025, respectively, there were long-term Medicare cost report settlement payables of $1,059,271 and $1,168,264 included on the consolidated balance sheets in total liabilities at March 31, 2026 and December 31, 2025, respectively. The total Medicare cost report settlement payables at March 31, 2026 are due as follows:
Related parties’ payables and accrued expenses are presented in Note 10.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||